The Indian pharmaceutical market grew 9.4 percent year-on-year (YoY) to Rs.129,015 crore in 2018. The growth, much faster than 2017, was led by uptake of drugs to treat chronic diseases and normalisation of supply chain after the disruption caused by GST. Both cardiac and anti-diabetes segments now constitute little over one-fifth of the Indian pharmaceutical market, an indication of the growing burden of chronic lifestyle diseases. Sales of multinational companies (MNCs) grew 8.3 percent in 2018. The top 10 drug makers contribute 43 percent to the Indian pharmaceutical market.

(Money Control)